The clinical efficacy and safety of naftopidil 75 mg on benign prostatic hyperplasia patients with moderate or severe urinary disturbance

The clinical efficacy and safety of naftopidil 75 mg on benign prostatic hyperplasia patients with moderate or severe urinary disturbance

We investigated the clinical efficacy and safety of administration of naftopidil at 75 mg for clinically benign hyperplasia patients who had moderate or severe urinary disturbance according to guidelines for clinical studies regarding urination disorder. Among patients with benign prostatic hyperpla...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 55(2009), 4 vom: 28. Apr., Seite 181-6
1. Verfasser: Tsujihata, Masao (VerfasserIn)
Weitere Verfasser: Yoshimura, Kazuhiro, Kojima, Yasuyuki, Oda, Masayoshi, Miyake, Osamu, Uchida, Kinya, Okuyama, Akihiko
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 2009
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:English Abstract Journal Article Adrenergic alpha-Antagonists Naphthalenes Piperazines naftopidil R9PHW59SFN